FDA Inspection 1255311 — Andrzej Emeryk, M.D.
The FDA completed an inspection of Andrzej Emeryk, M.D. on Nov 18, 2024 in Lublin. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 18, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Lublin (Poland)
Additional details
Clinical Investigator (CI)